Skip to content

Development and evaluation of appropriate technology for hypertension management and medical prevention integration based on Internet + artificial intelligence

Development and evaluation of appropriate technology for hypertension management and medical prevention integration based on Internet + artificial intelligence

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098845
Enrollment
Unknown
Registered
2025-03-14
Start date
2024-12-21
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Group 1:The 12 community health service centers under the jurisdiction of the Third People's Hospital of Longgang District, Shenzhen, were randomly divided into four groups using community health cent
Group 2:The 12 community health service centers under the jurisdiction of the Third People's Hospital of Longgang District, Shenzhen, were randomly divided into four groups using community health cent

Sponsors

Fuwai Hospital Chinese Academy of Medical Sciences·Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 35 years. 2. Permanent resident of Shenzhen (residing for >= 6 months). 3. Enrolled with a family doctor at the participating community health service center and attending regular follow-up visits (at least 3 standard follow-up visits between January 1, 2024, and December 1, 2024, including at least 1 outpatient visit). 4. Diagnosed with primary hypertension. 5. Recent follow-up BP was above 140 / 90mmHg. 6. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who meet the referral criteria. 2. Individuals unwilling to take antihypertensive medications. 3. Intolerance to two or more of the four classes of antihypertensive drugs, including A, B, C, or D. 4. Diagnosed by a physician or self-reported chronic kidney disease with eGFR < 60 ml/min·1.73m^2 or currently receiving dialysis. 5. Coexisting severe diseases diagnosed by a physician or self-reported by the patient, such as malignant tumors, liver failure, etc. 6. Self-reported physician-diagnosed atrial fibrillation. 7. Currently in the acute phase of any disease or an unstable condition. 8. Presence of cognitive, communication, or other impairments.

Design outcomes

Primary

MeasureTime frame
Systolic Blood Pressure;

Secondary

MeasureTime frame
Diastolic Blood Pressure;Management rate of hypertensive patient;Control rate of hypertension in managed crowd;Compliance Rate of Hypertension Management by Community Health Physicians;

Countries

China

Contacts

Public ContactLi Yichong

Fuwai Hospital Chinese Academy of Medical Sciences·Shenzhen

yichongli.cvd@139.com+86 755 8218 0028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026